These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33441730)

  • 21. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features.
    Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M
    Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
    Dai Y; Wu Z; Wang F; Zhang Z; Yu M
    Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD
    PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT.
    Danielescu C; Zugun-Eloae F; Zlei M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment.
    Ding N; Luo S; Yu J; Zhou Y; Wu Z
    Mol Vis; 2018; 24():252-260. PubMed ID: 29618920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.
    Loukovaara S; Lehti K; Robciuc A; Pessi T; Holopainen JM; Koli K; Immonen I; Keski-Oja J
    Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):881-8. PubMed ID: 24218041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.
    Ricker LJ; Altara R; Goezinne F; Hendrikse F; Kijlstra A; La Heij EC
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4256-62. PubMed ID: 21372012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive exploration of hub genes involved in oxidative stress in rhegmatogenous retinal detachment based on bioinformatics analysis.
    Xu Q; Luo L; Xiang X; Feng Y; Cao Y; Zeng J; Lv H
    Exp Eye Res; 2024 Mar; 240():109810. PubMed ID: 38296106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P and secretoneurin in vitreous aspirates of patients with various vitreoretinal diseases.
    Lorenz K; Troger J; Fischer-Colbrie R; Kremser B; Schmid E; Kralinger M; Teuchner B; Bechrakis N; Kieselbach G
    Peptides; 2008 Sep; 29(9):1561-5. PubMed ID: 18550223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
    Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment.
    Naveh N; Belkin M; Ben-Chaim O; Weissman C; Treister G
    Ophthalmic Res; 1990; 22(1):3-11. PubMed ID: 2111530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component.
    Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC
    Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.
    Coral K; Angayarkanni N; Gomathy N; Bharathselvi M; Pukhraj R; Rupak R
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3607-12. PubMed ID: 19369240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
    Ichinohasama R; Nishiguchi KM; Fujita K; Aizawa N; Inoue T; Sasaki E; Kunikata H; Nakazawa T
    Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.